Related Experiment Videos
In vivo flow cytometry: a new method for enumerating circulating cancer cells
Irene Georgakoudi1, Nicolas Solban, John Novak
1Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, 40 Blossom Street, BHX630, Boston, MA 02114, USA.
Cancer Research
|August 4, 2004
Summary
This study introduces in vivo flow cytometry to quantify circulating tumor cells. Prostate cancer cell behavior in circulation depends on both intrinsic cell properties and the host environment.
Area of Science:
- Oncology
- Cell Biology
- Biotechnology
Background:
- Circulating tumor cells (CTCs) are crucial for distant metastasis.
- Understanding CTC fate is vital for cancer progression research.
Purpose of the Study:
- To quantitatively detect CTCs using in vivo flow cytometry.
- To investigate the circulation kinetics of prostate cancer cell lines.
- To determine factors influencing CTC survival and clearance.
Main Methods:
- Development and application of in vivo flow cytometry.
- Analysis of two prostate cancer cell lines with varying metastatic potential.
- Assessment in mouse and rat models.
Main Results:
- In vivo flow cytometry enables quantitative detection of CTCs.
- Circulation kinetics are influenced by both cell line properties and host environment.
- Intrinsic cell properties dictate early CTC clearance, while host factors affect later circulation.
Conclusions:
- In vivo flow cytometry is a powerful tool for CTC analysis.
- Prostate cancer cell fate in circulation is multifactorial.
- Host-tumor interactions significantly impact metastatic potential.